SONM stock news
This page provides real-time market news, earnings updates, and company announcements related to DNA X, Inc. (SONM).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-24 21:31 EST
ATXG Rallies 50% Pre-Market on Rumored Asia-Pacific Lending Deal
101 finance2026-03-18 14:24:43
New Vishay Intertechnology Space-Grade Common Mode Choke Provides EMI Filtering for GaN and SiC Switching Applications
Finviz2026-03-18 15:03:10
VNRX Surges 24% on ctDNA Breakthrough — But Broader Market Drags It Down
101 finance2026-03-18 16:13:05
Cardiff Oncology's Onvansertib Approaches Critical 2026 Deadline to Prove PLK1 Inhibition S-Curve Validity
101 finance2026-03-19 11:18:48
3 Lesser-Known Stocks Showing Potential Risks
101 finance2026-03-19 13:30:48
DoorDash’s Paid Task Program Ignites Data Flywheel for Autonomous Delivery Breakthrough
101 finance2026-03-19 15:21:48
NEO Rallies 6.5% as RaDaR ST Targets $20B MRD Market
101 finance2026-03-20 00:15:57
MDA SPACE ANNOUNCES EXERCISE OF OVER-ALLOTMENT OPTION IN INITIAL PUBLIC OFFERING IN THE UNITED STATES
Finviz2026-03-20 13:09:51
Bold Therapeutics' BOLD-100 Pipeline Hinges on High-Stakes BIO-Europe Spring Deals
101 finance2026-03-20 13:21:51
1 Stock That Hasn't Delivered Profits for Years and 2 Encountering Challenges
101 finance2026-03-20 16:30:50
Agilent's 0.40% Stock Decline Contrasts 59.18% Volume Surge Ranking 454th as AI Automation and Strategic Partnerships Fuel Investor Interest
101 finance2026-03-21 01:01:13
INO Encounters Manufacturing Deficiency Issue During FDA Discussion—Potential Regulatory Denial Threatens
101 finance2026-03-22 13:52:12
Dairy Queen's $10B Growth: A Flow Analysis of Buffett's Wisdom to Unit Economics
101 finance2026-03-23 00:45:42
HyBryte Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026
Finviz2026-03-23 11:30:59
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
Finviz2026-03-23 11:36:10
OSR Holdings Updates $815 Million VXM01 Licensing Deal Structure to Capture Value at Parent Level
Finviz2026-03-23 12:45:55
Tempus AI’s diagnostic and data divisions Propel Sustainable Growth Over Time
101 finance2026-03-23 17:21:42
DVI’s Transition of Leadership to Client Engagement Roles Bolsters the Quiet Quality Investment Strategy
101 finance2026-03-23 19:39:40
Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights
Finviz2026-03-23 20:09:49
Imunon’s ATM Overhang Indicates a Shift in Biotech Toward Higher-Quality Investments
101 finance2026-03-23 21:12:47
Racura Oncology Faces Binary Test at March 24 Symposium: Premium Valuation Hinges on Scientific Proof
101 finance2026-03-24 03:33:58
Actuate Therapeutics: Poised for Potential $200M+ Pediatric Priority Review Vouchers and Transformative Combinations in RAS-Driven Cancers
Finviz2026-03-24 11:03:56
Obagi Medical Introduces NU-GEN Cellular Renewal Serum Designed to Visibly Rewind Skin's Age and Restore Visible Youthfulness
Finviz2026-03-24 12:39:48
Biocardia Inc's HF2 Trial Enrollment and Regulatory Timeline Claims Clash in 2025 Earnings Calls
101 finance2026-03-25 00:13:03
3 Lesser-Known Stocks Showing Potential Risks
101 finance2026-03-19 13:30:48
DoorDash’s Paid Task Program Ignites Data Flywheel for Autonomous Delivery Breakthrough
101 finance2026-03-19 15:21:48
NEO Rallies 6.5% as RaDaR ST Targets $20B MRD Market
101 finance2026-03-20 00:15:57
MDA SPACE ANNOUNCES EXERCISE OF OVER-ALLOTMENT OPTION IN INITIAL PUBLIC OFFERING IN THE UNITED STATES
Finviz2026-03-20 13:09:51
Bold Therapeutics' BOLD-100 Pipeline Hinges on High-Stakes BIO-Europe Spring Deals
101 finance2026-03-20 13:21:51
1 Stock That Hasn't Delivered Profits for Years and 2 Encountering Challenges
101 finance2026-03-20 16:30:50
Agilent's 0.40% Stock Decline Contrasts 59.18% Volume Surge Ranking 454th as AI Automation and Strategic Partnerships Fuel Investor Interest
101 finance2026-03-21 01:01:13
INO Encounters Manufacturing Deficiency Issue During FDA Discussion—Potential Regulatory Denial Threatens
101 finance2026-03-22 13:52:12
Dairy Queen's $10B Growth: A Flow Analysis of Buffett's Wisdom to Unit Economics
101 finance2026-03-23 00:45:42
HyBryte Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026
Finviz2026-03-23 11:30:59
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
Finviz2026-03-23 11:36:10
OSR Holdings Updates $815 Million VXM01 Licensing Deal Structure to Capture Value at Parent Level
Finviz2026-03-23 12:45:55
Tempus AI’s diagnostic and data divisions Propel Sustainable Growth Over Time
101 finance2026-03-23 17:21:42
DVI’s Transition of Leadership to Client Engagement Roles Bolsters the Quiet Quality Investment Strategy
101 finance2026-03-23 19:39:40
Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights
Finviz2026-03-23 20:09:49
Imunon’s ATM Overhang Indicates a Shift in Biotech Toward Higher-Quality Investments
101 finance2026-03-23 21:12:47
Racura Oncology Faces Binary Test at March 24 Symposium: Premium Valuation Hinges on Scientific Proof
101 finance2026-03-24 03:33:58
Actuate Therapeutics: Poised for Potential $200M+ Pediatric Priority Review Vouchers and Transformative Combinations in RAS-Driven Cancers
Finviz2026-03-24 11:03:56
Obagi Medical Introduces NU-GEN Cellular Renewal Serum Designed to Visibly Rewind Skin's Age and Restore Visible Youthfulness
Finviz2026-03-24 12:39:48
Biocardia Inc's HF2 Trial Enrollment and Regulatory Timeline Claims Clash in 2025 Earnings Calls
101 finance2026-03-25 00:13:03
SONM stock chart
SONM stock detailsSONM stock price change
On the last trading day, SONM stock closed at 2.90 USD, with a price change of -13.43% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more